Rita Perlingeiro

Rita Perlingeiro
Associate Professor
University of Minnesota
USA

Biography

Dr. Rita Perlingeiro has received her PhD from the University of Campinas (UNICAMP, Sao Paulo, Brazil), in which she studied erythroid progenitor cell biology in the context of sickle cell disease. Following, Dr. Perlingeiro moved to Boston, where she did her postdoctoral training at the Whitehead Institute/MIT in the laboratory of Dr. George Daley, focusing on the generation of hematopoietic stem/progenitor cells from pluripotent stem cells. Currently, she is an Associate Professor of Medicine within the Lillehei Heart Institute at the University of Minnesota. Her primary research interests include understanding the molecular mechanisms controlling lineage-specific differentiation of pluripotent stem cells, and applying this information to efficiently generate tissue-specific stem/progenitor cells endowed with in vivo regenerative potential. She has received several awards and honors, including: National Scientist Development Award from the American Heart Association and a Lillehei Professorship in Stem Cell and Regenerative Cardiovascular Medicine. She is serving as an editorial member of several journals, including Skeletal Muscle, Journal of Stem Cell Research and Therapy, and Stem Cell Reviews and Reports. She has served as an expert reviewer for several journals, such as Nature Medicine, Cell Stem Cell, Science, Molecular Therapy, Nature Communications, Blood, Development, Stem Cells, among others. She has published more than 45 articles in peer-reviewed journals and is an author of 1 book chapter. She is a member of the American Society of Gene and Cell Therapy, American Society of Hematology, International Society for Stem Cell Research, and American Heart Association.

Research Interest

Her primary research interests include understanding the molecular mechanisms controlling lineage-specific differentiation of pluripotent stem cells, and applying this information to efficiently generate tissue-specific stem/progenitor cells endowed with in vivo regenerative potential.